Form 8-K LA JOLLA PHARMACEUTICAL For: May 14StreetInsider.com - Form 8-K LA JOLLA PHARMACEUTICAL For: Street Insider, 1 day ago |
See all (645) images for "la jolla" | ||||
BEAUTIFUL TORREY PINES STATE RESERVECNN PRODUCER NOTE says she and her son ventured to Torrey Pines State Reserve in La Jolla, California, after he needed to earn some extra credit for his geology class. She says her son did a self-guided walking tour of the area, where people ... CNN, 1 day ago
|
La Jolla Pharmaceutical completes Phase I chronic kidney disease trialLa Jolla Pharmaceutical Company, a developer of therapeutics targeting galectin proteins, has announced the completion of Phase I trial with the treatment of the last patient in the Phase I, or Part A, portion of the Phase I/II clinical trial of ... Individual.com, 2 days ago
La Jolla Pharmaceutical Company (LJPC) Announces First-Quarter 2013 Financial Results and Highlights Recent Corporate Progress
BioSpace, 3 days ago
La Jolla Pharmaceutical Company Presents Corporate Update at the MoneyShow
NewsBlaze, 3 days ago
La Jolla Pharmaceutical Company Announces First-Quarter 2013 Financial Results and Highlights Recent Corporate Progress
Individual.com, 4 days ago
|
Kathleen "Kat" Jennings, CEO and Founder of TaxConnections, Continues Full Speed Ahead on Her Mission to Save Consumers From Higher Taxes While Offering Tax Professionals a Powerful Marketing ToolLA JOLLA, Calif. Jennings previously founded ET Search, Inc., a specialized tax executive search firm, in 1980. Widely considered the leading tax executive search firm of its kind anywhere, ET Search, Inc. has enabled Jennings to develop a vast ... PR Newswire, 3 days ago
Kathleen Kat Jennings, CEO and Founder of TaxConnections, Continues Full Speed Ahead on Her Mission to Save Consumers From Higher Taxes While Offering Tax Professionals a Powerful Marketing Tool
TMC Net, 2 days ago
|
Public Sleep Apnea Awareness Event Being Held In La Jolla, CA With...continues to spread awareness of the deadly disorder, sleep apnea with NFL greats. The next event will be hosted by one of the most well-known and like sleep specialists in the country, Dr. Bradley Eli. Dr. Bradley Eli (PPHA) is continuing their ... PRWeb, 2 days ago
Marshall Faulk and Mike Haynes along with Many NFL Greats Back Pro...
PRWeb, 1 day ago
|
RuiYi y Genor BioPharma colaboran en el desarrollo en China de RYI-008- , un nuevo terapéutico para enfermedades autoinmunes y cáncer LA JOLLA, California "RYI-008, con su potencia femtamolar sin precedentes y larga duración de vida, tiene un perfil terapéutico de una dosis subcutánea, de bajo miligramo, una vez ... PR Newswire, 2 days ago
With a band of biotech collaborators, RuiYi sets sail developing new biologic drugs for China
MedCity News, 2 days ago
RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer
DNA India, 2 days ago
RuiYi Licenses mAb Development to China's Genor
Genetic Engineering News, 2 days ago
|
RuiYi et Genor BioPharma collaborent au développement du RYI-008 en Chine, un nouveau traitement contre les maladies auto-immunes et le cancerLA JOLLA « Grce à sa puissance femtomolaire sans précédent et à une durée de vie incroyablement longue, le RYI-008 présente un profil thérapeutique de dosage sous-cutané à faible milligramme et administré une fois par mois, » a déclaré ... PR Newswire, 2 days ago
|
Dr. Garber's Natural Solutions Now Available at Whole Foods Market, La Jolla, CA( full line, ® is pleased to announce that their condition specific remedies are now available in Whole Foods Markets at 8825 Villa La Jolla Drive, La Jolla, CA 92037. Represented by Brandstorm HBC (Los Angeles, CA), the all-natural remedies are ... PRWeb, 2 days ago
Dr. Garber's Natural Solutions Announced at Whole Foods Market in La Jolla
Broadway World, 2 days ago
|
RuiYi und Genor BioPharma arbeiten in China bei der Entwicklung von RYI-008 zusammen, einer neuen Therapie für Autoimmunerkrankungen und KrebsLA JOLLA „Mit seiner bisher noch nie da gewesenen femtomolaren Potenz und einer erstaunlichen Halbwertzeit verfügt RYI-008 über ein therapeutisches Profil mit einmal monatlicher, subkutaner Dosierung im niedrigen Milligrammbereich", erklärt ... PR Newswire, 2 days ago
|
Research Team Publishes New Methods for Synthetic Generation of Influenza VaccinesLA JOLLA, Calif. The team led by first author Philip R. Dormitzer "Our teams have been working hard to put our combined expertise to work toward the development of next generation vaccines," said Dr. Venter, CEO and Founder of JCVI and SGI. "We ... PR Newswire, 2 days ago
More from: , ADVFN UK...and 5 other sources
|